Free shipping on all orders over $ 500


Cat. No. M1796
XAV939 Structure

NVP-XAV939; XAV-939

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 45  USD45 In stock
10mg USD 55  USD55 In stock
25mg USD 120  USD120 In stock
50mg USD 185  USD185 In stock
100mg USD 285  USD285 In stock
200mg USD 475  USD475 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

XAV939 is an inhibitor of Tankryases with IC50 values of 11 and 4nM for Tankyrase 1 and Tankyrase 2, respectively. It stimulates beta-catenin degradation by stabilizing axin, resulting in the inhibition of the canonical Wnt pathway. Wnt proteins act on a variety of stem cells that include neural, mammary and embryonic stem cells. XAV939 increases the protein levels of the axin-GSK3β complex and promotes the degradation of β-catenin in SW480 cells. In addition, XAV939 inhibits growth of DLD-1 cells, an APC-deficient colorectal cancer cell line.

Product Citations
Customer Product Validations & Biological Datas
Source Customer experimental result (2019 Jan). XAV939 obtained from AbMole
Method treat liver in regeneration
Cell Lines
Concentrations 50uM
Incubation Time -
Results XAV939 treat liver in regeneration
Source Eur Med Pharmacol Sci (2017). XVA 939, Figure 4. (AbMole BioScience)
Cell Lines
Concentrations 2 mg/ml
Incubation Time 30 min
Results Wnt inhibitor XAV 939 was significantly inhibited the up-regulation of Wnt and phosphorylated-β-catenin and increased phosphorylated-GSK-3β expression in the hippocampus in ISA and SEA groups, as compared with the control group at 5 weeks (Figure 4 A, B, C, p < 0.05).
Source Eur Med Pharmacol Sci (2017). XVA 939, Figure 3. (AbMole BioScience)
Cell Lines
Concentrations 2 mg/ml
Incubation Time 30 min
Results As shown in Figure 3, the expression levels of Wnt3a and β-catenin (Figure 3A, C, p < 0.05) were significantly reduced after Wnt inhibitor XAV 939 treatment, while GSK-3β expression level was dramatically increased in ISAI and SEAI groups (Figure 3B, p < 0.05).
Source Eur Med Pharmacol Sci (2017). XVA 939, Figure 2. (AbMole BioScience)
Cell Lines
Concentrations 2 mg/ml
Incubation Time 30 min
Results P7 rats treated with Wnt inhibitor XAV 939 could markedly relief that damage. Those morphological changes were significantly moderated and reduced neuronal loss at 10-week (Figure 2).
Source Eur Med Pharmacol Sci (2017). XVA 939, Figure 1. (AbMole BioScience)
Cell Lines
Concentrations 2 mg/ml
Incubation Time 30 min
Results When rats were treated with Wnt inhibitor XAV 939 at 30 min before anesthesia, the impairment of brain could relieve. These findings suggested that impairment of learning and memory in P7 rats may through the Wnt signaling pathway.
Protocol (for reference only)
Cell Experiment
Cell lines B-T549, MDA-MB-231, HCC-1143 and HCC-1937 cell lines
Preparation method Cell viability assay. Cells were seeded at 20,000 cells/well into 96-well plates. After overnight incubation, cells were treated with DMSO or each Wnt inhibitor (iCRT-3, 75 μM; iCRT-5, 200 μM; iCRT-14, 50 μM; IWP-4, 5 μM and XAV-939, 10 μM) for 48 hours. Cell viability was determined using the Cell Titer-Glo luminescent cell viability assay kit (Promega) according to the manufacturer’s instructions. Luminescence was measured using FLUOstar microplate reader. All treatments were performed in triplicate, and each experiment was repeated three times.
Concentrations 10 μM
Incubation time 48 hr
Animal Experiment
Animal models bleomycin-induced dermal fibcrosis mice model
Formulation 10% DMSO / 90% normal saline
Dosages 2.5 mg/kg, four times a day
Administration Intraperitoneal injection
Chemical Information
Molecular Weight 312.3
Formula C14H11F3N2OS
CAS Number 284028-89-3
Solubility (25°C) DMSO 11 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.


[1] Ming-Yue Zhou, et al. Front Neurosci . Diprotin A TFA Exerts Neurovascular Protection in Ischemic Cerebral Stroke

[2] Bilir B, et al. J Transl Med. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.

[3] Distler A, et al. Ann Rheum Dis. Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling.

Related Wnt/beta-catenin Products

Fz7-21 (Ac-LPSDDLEFWCHVMY-NH2) is a potent peptide antagonist of FZD7 receptors , selectively binds to FZD7 CRD subclass and alters the conformation of the CRD and the architecture of its lipid-binding groove.

FZD7 antagonist 1

FZD7 antagonist 1 (peptide 34) is a dFz7-21 analogue.


NLS-StAx-h is a selective, cell permeable, stapled peptide Wnt signaling inhibitor with an IC50 of 1.4 μM.


Zamaporvint is an orally active, selective Wnt inhibitor that targets the membrane-bound o-acyltransferase porcupine and inhibits Wnt ligand palmitoylation, secretion and pathway activation. In addition, Zamaporvint displays potent antiproliferative effects in Wnt ligand-dependent colorectal and pancreatic cell lines. It can be used in cancer-related studies.


Foxy-5, a WNT5A agonist and a mimetic peptide of WNT5A, triggers cytoplasmic free calcium signaling without affecting β-catenin activation and inhibits migration and invasion of epithelial cancer cells.Foxy-5 effectively reduces metastatic spread of prostate cancer cells with low WNT5A expression in an in situ mouse model.

Abmole Inhibitor Catalog

Keywords: XAV939, NVP-XAV939; XAV-939 supplier, Wnt/beta-catenin, inhibitors, activators

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.